CWM
RMD icon

Calamos Wealth Management’s ResMed RMD Stock Holding History

Calamos Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-12,654
Closed -$908K – 238
2015
Q1 		$908K Buy
+12,654
New +$822K 0.23% 145

Other funds holding RMD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Calamos Wealth Management's RMD Position: Q2 2015 in Review

Calamos Wealth Management sold out of ResMed (RMD) in Q2 2015, closing a stake of 12,654 shares — an estimated $908K sold.

Calamos Wealth Management first reported a position in RMD in Q1 2015 and held it in 1 quarter. The position peaked at $908K in Q1 2015. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2015.

  • Calamos Wealth Management reported no remaining ResMed position as of Q2 2015 after selling out during the quarter.
  • Calamos Wealth Management sold 12,654 ResMed shares in Q2 2015, an estimated $908K.
  • Calamos Wealth Management first reported a position in ResMed in Q1 2015 and held it in 1 quarter.
  • Calamos Wealth Management's ResMed position peaked at $908K in Q1 2015.
  • 312 funds tracked by Wall St. Rank held ResMed as of Q2 2015.

Based on Calamos Wealth Management's 13F filing for Q2 2015, filed 17 Aug 2015.